A study from Uganda found that point-of-care CRP had 89% sensitivity and 72% specificity for culture-confirmed TB among patients with CD4 count ≤350 cells/mm3 (regardless of symptoms) who were initiating ART [18]. The gene discussed is CD4; the disease is tuberculosis.